Naitee Ting
Past Vice President for Strategies & Development
Naitee Ting is a Fellow of American
Statistical Association (ASA). He is
currently a Director in the Department of
Biostatistics and Data Sciences at
Boehringer-Ingelheim Pharmaceuticals
Inc. (BI). He joined BI in September of
2009, and before joining BI, he was at Pfizer
Inc. for 22 years (1987-2009). Naitee
received his Ph.D. in 1987 from Colorado
State University (major in Statistics). He
has an M.S. degree from Mississippi State
University (1979, Statistics) and a
B.S. degree from College of Chinese Culture
(1976, Forestry) at Taipei, Taiwan.
Naitee
published articles in Technometrics,
Statistics in Medicine, Drug Information
Journal, Journal of Statistical Planning and
Inference, Journal of Biopharmaceutical
Statistics, Biometrical Journal, Statistics
and Probability Letters, and Journal of
Statistical Computation and Simulation. His
book "Dose Finding in Drug Development" was
published in 2006 by Springer, and is
considered as the leading reference in the
field of dose response clinical trials. The
book "Fundamental Concepts for New Clinical
Trialists", co-authored with Scott Evans, was
published by CRC in 2015. Another book
"Phase II Clinical Development of New Drugs",
co-authored with Chen, Ho, and Cappelleri was
published in 2017 (Springer). Naitee is an
adjunct professor of Columbia University and
University of Connecticut. Naitee has been
an active member of both the ASA and the
International Chinese Statistical Association
(ICSA).
